Silverberg Bernstein Capital Management LLC

Position in NAGE — Niagen Bioscience, Inc.

CIK 2007880 ARMONK, NY

Position in NAGE

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$448,520

-$160,509 QoQ

Shares Held

140,602

+1.8% QoQ

Ownership

0.177%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

of 7 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Jun 30, 2026

Silverberg Bernstein Capital Management LLC holds $4,403,020 across 4 Biotechnology names. NAGE ranks #3 (10.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MDWD	MediWound Ltd.	228,137	$3,353,613
2	PHAR	Pharming Group N.V.	41,547	$577,087
3	NAGE	Niagen Bioscience, Inc. This page	140,602	$448,520
4	ACIU	AC Immune SA	10,000	$23,800

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$448,520	140,602	+1.8%	Shares	Sole	2026-07-07
2026-03-31	$609,029	138,102	+5.3%	Shares	Sole	2026-04-16
2025-12-31	$834,190	131,162	+4.7%	Shares	Sole	2026-01-12
2025-09-30	$1,168,694	125,262	+25.9%	Shares	Sole	2025-10-07
2025-06-30	$1,433,449	99,476	+4.1%	Shares	Sole	2025-07-09
2025-03-31	$659,205	95,537	+18.6%	Shares	Sole	2025-04-10
2024-12-31	$427,651	80,537	-3.3%	Shares	Sole	2025-01-14
2024-09-30	$303,888	83,257	+1.3%	Shares	Sole	2024-10-04
2024-06-30	$224,288	82,157	0.0%	Shares	Sole	2024-07-12
2024-03-31	$285,906	82,157	-0.7%	Shares	Sole	2024-04-11
2023-12-31	$118,342	82,757	—	Shares	Sole	2024-01-17
No filing history on record for this holder in this stock.